Results 121 to 130 of about 6,568,172 (215)

A SHAP-Informed Formal Feature Attribution Framework for Drug-Drug Interaction Risk in Large-Scale Claims Data. [PDF]

Clin Transl Sci
Dixon RJ, Price ET.
europepmc   +1 more source

Drug Utilization Patterns and Potential Drug-Drug Interaction Burden in Respiratory Prescriptions: A Real-World Community Pharmacy Study. [PDF]

Pharmaceuticals (Basel)
Drăgoi MM, Chis AR, Ardelean SM, Udrescu M, Suciu L, Udrescu L.   +5 more
europepmc   +1 more source

Global management of drug-drug interaction in patients with prostate cancer: international survey by Meet-URO group and ONCOassist. [PDF]

Oncologist
Valsecchi AA, Maffezzoli M, Cursano MC, Di Civita M, Santamaria F, Kingspergher S, Zanardi E, Procopio G, Ashok S, Ramachandran L, George R, Bambury K, Bambury R, O'Carroll E, Banna GL, Di Maio M, Santini D.   +16 more
europepmc   +1 more source

Correction: Chorismate synthase mediates cerebral malaria pathogenesis by eliciting salicylic acid-dependent autophagy response in parasite

Biology Open
Malabika Chakrabarti, Deepika Kannan, Akshay Munjal, Hadi Hasan Choudhary, Satish Mishra, Subhash Singh, Shailja Singh   +6 more
doaj   +1 more source

Real-World Claims Data on Prescribed Drugs and the Associated Drug-Drug Interaction Risk in Sickle Cell Disease in the United States. [PDF]

Clin Transl Sci
Nørgaard RA, Grenier L, Bruun-Rasmussen P, Osunkwo I, Säll C.   +4 more
europepmc   +1 more source

Pharmacokinetic Drug-Drug Interaction Potential of Oral Anticancer Drugs. [PDF]

Clin Pharmacol Ther
Alhurayri F, Younis IR, Jalal SI, Logan TF, Maniar R, Bray SM, Quinney SK, Desta Z, Skaar TC, Tisdale JE, Shugg T.   +10 more
europepmc   +1 more source

Molecular mechanisms of YZG-331 ameliorated insomnia based on the gut microbiota-drug interaction. [PDF]

Acta Pharm Sin B
Zuo H, Guo Q, Zhao B, Lu J, Feng R, Wang J, Song J, Jin J, Hu J, Zhao Y, Xu H, Yuan T, Wang W, Tu Y, Wei L, Zhao Y, Hui X, Liu Z, Sheng L, Li Y, Zhang J, Sun J, Shi J, Wang Y.   +23 more
europepmc   +1 more source

The EMA Qualification Opinion for CYP Inhibition-Mediated Drug-Drug Interaction Predictions: Implications for PBPK Credibility Assessment in the Era of ICH M15. [PDF]

Clin Pharmacol Ther
Rowland Yeo K, Neuhoff S, Hatley O, Gardner I, Brochot C, Bois FY, Jamei M.   +6 more
europepmc   +1 more source

Corrigendum to “Effect of a probiotic mixture on the biotransformation and bioavailability of deglycosylated ginsenosides” [J. Funct. Foods 133 (2025) 107015]

Journal of Functional Foods
So Yeon Jeon, Jihoon Lee, Ji-Hyeon Jeon, Juyoung Kim, Yeon-Ju Baek, Min-Koo Choi, Soohyun Sung, Jong Won Kim, Sanghyun Lim, Im-Sook Song   +9 more
doaj   +1 more source

Exploratory prescribing risk profiles and drug drug interaction burden in older adults with depressive episodes. [PDF]

Front Psychiatry
Goldiş FD, Ardelean SM, Udrescu L.
europepmc   +1 more source